The “Prefilled Syringe Fill / Finish Service Providers, 2020-2030>>>

Key Inclusions
A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes, along with analyses based on a number of relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), location of the headquarters, location of fill / finish facilities, type of drug molecule (small molecule and biologic), syringe barrel material (glass and plastic), syringe fill volume and additional services offered (drug formulation, regulatory support, labelling and packaging, terminal sterilization, storage and logistics). In addition, the chapter includes details on prefilled syringe fill / finish installed capacity of the service providers.   
Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific. Each profile provides an overview of the company, information on its overall service portfolio, fill / finish facilities, financial performance (if available), and details on recent developments as well as an informed future outlook.
An analysis of the recent developments (since 2015) pertaining to contract fill / finish services, based on various parameters, such as year of development, type of activity / development (collaboration and expansions), scale of operation of the project, location of expanded facility, type of drug molecule involved and additional services offered.
An estimate of the global, contract fill / finish capacity of prefilled syringes, by taking into consideration the capacities of various fill / finish service providers (as available on respective company websites), collected via secondary and primary research. The study examines the distribution of number of prefilled syringe units and volume of drug filled, based on the company size of manufacturer (small-sized, mid-sized and large), scale of operation (preclinical / clinical and commercial), location of headquarters and fill / finish facilities (North America, Europe and Asia-Pacific) and type of drug molecule (small molecule and biologics).
An informed estimate of the annual demand for fill / finish of prefilled syringes (in number of units), taking into account the marketed drugs available in prefilled syringes and other relevant parameters, such as target patient population, dosing frequency and dose strength. The study provides the distribution of the annual demand, based on the geography (North America (US), Europe (UK, France, Italy, Spain, Germany and rest of Europe), Latin America (Brazil, Mexico, Argentina and rest of Latin America), Asia-Pacific (Japan, China, India, South Korea and rest of Asia-Pacific), and the Middle East and Africa (Saudi Arabia, UAE, Africa and rest of the Middle East)), type of drug molecule (small molecule and biologics), therapeutic area (blood disorders, infectious diseases, metabolic disorders, oncological disorders and others), syringe barrel material (glass and plastic) and number of barrel chambers (single chamber and dual chamber).
A detailed demand and supply assessment of geographies, based on a number of parameters, such as the number of prefilled syringe combination product developers, number of prefilled syringe manufacturers, number of prefilled syringe fill / finish service providers, number of prefilled syringe fill / finish facilities, capacity and demand for prefilled syringes in that particular geographical region.
An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe fill / finish service providers, based on different parameters, such as developer strength, pipeline strength, type of drug molecule, target therapeutic area and location of the headquarters of the company.
A discussion on the potential growth areas, such as growing injectable drugs pipeline, increasing popularity of prefilled syringes, rise in preference for  outsourcing of fill / finish operations, technological advancements in aseptic fill / finish processes, and growing opportunities in the Asia-Pacific region.
A review of the landscape of prefilled syringe manufacturers, featuring a list of key prefilled syringes and their manufacturers, analyzed based on a number of relevant parameters, such as syringe barrel material (glass and plastic), number of barrel chambers (single chamber and dual chamber), type of needle system (fixed needle system, luer lock and luer cone) barrel volume, year of establishment and location of the headquarters of manufacturers.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
  • Scale of Operation
Preclinical / Clinical
  • Type of drug molecule
Small Molecule
  • Target therapeutic area
Blood disorders
Infectious diseases
Metabolic disorders
Oncological disorders
Neurological disorders
Autoimmune disorders
  • Syringe barrel material
  • Number of barrel chambers
Single chamber
Dual chamber
  • Key Geographical Regions
North America
Latin America
Middle East and Africa
To request sample pages, please visit this link
Key Questions Answered
  • Who are the key players offering fill / finish in prefilled syringes, across the globe?
  • What is the current, installed capacity for fill / finish in prefilled syringes?
  • What is the annual, demand for prefilled syringes, at both clinical and commercial scales?
  • What are the key geographical hubs of fill / finish services for prefilled syringes?
  • What are the key growth drivers within this domain?
  • How is the current and future market opportunity likely to be distributed across key market segments?
You may also be interested in the following titles:
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]

You may also like


No comments yet... Be the first to leave a reply! Login here

0 Karma
1153 Posts

Made with by Mamby